Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Net Cash Flow (2021 - 2025)

Historic Net Cash Flow for Core Scientific (CORZ) over the last 5 years, with Q3 2025 value amounting to -$127.9 million.

  • Core Scientific's Net Cash Flow fell 18162.38% to -$127.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $199.6 million, marking a year-over-year increase of 515.22%. This contributed to the annual value of $767.3 million for FY2024, which is 429218.62% up from last year.
  • Latest data reveals that Core Scientific reported Net Cash Flow of -$127.9 million as of Q3 2025, which was down 18162.38% from -$117.4 million recorded in Q2 2025.
  • In the past 5 years, Core Scientific's Net Cash Flow ranged from a high of $583.2 million in Q4 2024 and a low of -$138.3 million during Q1 2025
  • For the 5-year period, Core Scientific's Net Cash Flow averaged around $23.4 million, with its median value being $7.5 million (2023).
  • As far as peak fluctuations go, Core Scientific's Net Cash Flow soared by 1001408.26% in 2024, and later tumbled by 58359.44% in 2025.
  • Quarter analysis of 5 years shows Core Scientific's Net Cash Flow stood at -$28.3 million in 2021, then skyrocketed by 151.52% to $14.6 million in 2022, then tumbled by 60.5% to $5.8 million in 2023, then soared by 10014.08% to $583.2 million in 2024, then tumbled by 121.93% to -$127.9 million in 2025.
  • Its Net Cash Flow stands at -$127.9 million for Q3 2025, versus -$117.4 million for Q2 2025 and -$138.3 million for Q1 2025.